Viewing Study NCT05371093


Ignite Creation Date: 2025-12-25 @ 1:26 AM
Ignite Modification Date: 2025-12-27 @ 11:11 PM
Study NCT ID: NCT05371093
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-15
First Post: 2022-05-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma
Sponsor: Kite, A Gilead Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module